Patents by Inventor Anna Wieckowska

Anna Wieckowska has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230117233
    Abstract: A group of novel 9H-fluorene derivatives suitable for the preparation of active substances for the treatment of Alzheimer's disease, in particular as multifunctional inhibitors of the BuChE and BACE1 enzymes and beta-amyloid aggregation.
    Type: Application
    Filed: May 20, 2021
    Publication date: April 20, 2023
    Inventors: Dawid Panek, Barbara Malawska, Anna PASIEKA, Jakub JONCZYK, Anna WIECKOWSKA, Justyna GODYN, Natalia SZALAJ, Marek Bajda, Kinga SALAT
  • Patent number: 8460943
    Abstract: A method of detecting liver damage in a subject comprises measuring the level of caspase-3 generated cytokeratin-18 fragments in the bodily sample. The level of measuring the level of caspase-3 generated cytokeratin-18 fragments is then correlated with liver disease progression.
    Type: Grant
    Filed: December 28, 2010
    Date of Patent: June 11, 2013
    Assignee: The Cleveland Clinic Foundation
    Inventors: Ariel E. Feldstein, Anna Wieckowska, Nizar Zein
  • Patent number: 8409878
    Abstract: A method of detecting liver damage in a subject comprises measuring the level of caspase-3 generated cytokeratin-18 fragments in the bodily sample. The level of measuring the level of caspase-3 generated cytokeratin-18 fragments is then correlated with liver disease progression.
    Type: Grant
    Filed: December 28, 2010
    Date of Patent: April 2, 2013
    Assignee: The Cleveland Clinic Foundation
    Inventors: Ariel E. Feldstein, Anna Wieckowska, Nizar Zein
  • Publication number: 20110244490
    Abstract: A method of detecting liver damage in a subject comprises measuring the level of caspase-3 generated cytokeratin-18 fragments in the bodily sample. The level of measuring the level of caspase-3 generated cytokeratin-18 fragments is then correlated with liver disease progression.
    Type: Application
    Filed: December 28, 2010
    Publication date: October 6, 2011
    Inventors: Ariel E. Feldstein, Anna Wieckowska, Nizar Zein
  • Publication number: 20110151488
    Abstract: A method of detecting liver damage in a subject comprises measuring the level of caspase-3 generated cytokeratin-18 fragments in the bodily sample. The level of measuring the level of caspase-3 generated cytokeratin-18 fragments is then correlated with liver disease progression.
    Type: Application
    Filed: December 28, 2010
    Publication date: June 23, 2011
    Inventors: Ariel E. Feldstein, Anna Wieckowska, Nizar Zein
  • Patent number: 7883904
    Abstract: A method of detecting liver damage in a subject comprises measuring the level of caspase-3 generated cytokeratin-18 fragments in the bodily sample. The level of measuring the level of caspase-3 generated cytokeratin-18 fragments is then correlated with liver disease progression.
    Type: Grant
    Filed: May 18, 2007
    Date of Patent: February 8, 2011
    Assignee: The Cleveland Clinic Foundation
    Inventors: Ariel E. Feldstein, Anna Wieckowska, Nizar Zein
  • Publication number: 20080081348
    Abstract: A method of detecting liver damage in a subject comprises measuring the level of caspase-3 generated cytokeratin-18 fragments in the bodily sample. The level of measuring the level of caspase-3 generated cytokeratin-18 fragments is then correlated with liver disease progression.
    Type: Application
    Filed: May 18, 2007
    Publication date: April 3, 2008
    Inventors: Ariel Feldstein, Anna Wieckowska, Nizar Zein